AAV-mediated gene therapy for metabolic diseases: dosage and reapplication studies in the molybdenum cofactor deficiency model
-
* Corresponding author: Rita Hahnewald r.hahnewald@gmx.de
Genetic Vaccines and Therapy 2009, 7:9 doi:10.1186/1479-0556-7-9
Accesses
- Last 30 days: 96 accesses
- Last 365 days: 953 accesses
- All time: 3689 accesses